Bryan D Griffin
Overview
Explore the profile of Bryan D Griffin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
1463
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Garnett L, Tran K, Schiffman Z, Muise K, Fletcher Q, Dzal Y, et al.
Viruses
. 2023 Sep;
15(9).
PMID: 37766234
Ebola virus is a zoonotic pathogen with a geographic range covering diverse ecosystems that are home to many potential reservoir species. Although researchers have detected Ebola virus RNA and serological...
2.
Gary E, Tursi N, Warner B, Cuismano G, Connors J, Parzych E, et al.
Front Immunol
. 2023 Mar;
14():1138609.
PMID: 36999023
Despite numerous clinically available vaccines and therapeutics, aged patients remain at increased risk for COVID-19 morbidity. Furthermore, various patient populations, including the aged can have suboptimal responses to SARS-CoV-2 vaccine...
3.
Tailor N, Warner B, Griffin B, Tierney K, Moffat E, Frost K, et al.
Viruses
. 2023 Jan;
15(1).
PMID: 36680125
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the aetiological agent of coronavirus disease 2019 (COVID-19) that has caused a pandemic with millions of human infections. There continues to be...
4.
Pickering B, Lung O, Maguire F, Kruczkiewicz P, Kotwa J, Buchanan T, et al.
Nat Microbiol
. 2022 Dec;
8(1):188.
PMID: 36509933
No abstract available.
5.
Pickering B, Lung O, Maguire F, Kruczkiewicz P, Kotwa J, Buchanan T, et al.
Nat Microbiol
. 2022 Nov;
7(12):2011-2024.
PMID: 36357713
Wildlife reservoirs of broad-host-range viruses have the potential to enable evolution of viral variants that can emerge to infect humans. In North America, there is phylogenomic evidence of continual transmission...
6.
Chan M, Tiwary M, Wu H, Tailor N, Vendramelli R, Audet J, et al.
J Virol
. 2022 Aug;
96(16):e0072822.
PMID: 35924920
The 1918 H1N1 influenza pandemic was among the most severe in history, taking the lives of approximately 50 million people worldwide, and novel prophylactic vaccines are urgently needed to prevent...
7.
Liu J, Budylowski P, Samson R, Griffin B, Babuadze G, Rathod B, et al.
Sci Adv
. 2022 Jan;
8(3):eabj9815.
PMID: 35044832
Safe and effective vaccines are needed to end the COVID-19 pandemic. Here, we report the preclinical development of a lipid nanoparticle–formulated SARS-CoV-2 mRNA vaccine, PTX-COVID19-B. PTX-COVID19-B was chosen among three...
8.
Griffin B, Warner B, Chan M, Valcourt E, Tailor N, Banadyga L, et al.
iScience
. 2021 Dec;
24(12):103530.
PMID: 34870132
The golden hamster model of SARS-CoV-2 infection recapitulates key characteristics of COVID-19. In this work we examined the influence of the route of exposure, sex, and age on SARS-CoV-2 pathogenesis...
9.
Griffin B, Corredor J, Pei Y, Nagy E
Viruses
. 2021 Nov;
13(11).
PMID: 34835017
Major histocompatibility complex class I (MHC-I) molecules play a critical role in the host's antiviral response by presenting virus-derived antigenic peptides to cytotoxic T lymphocytes (CTLs), enabling the clearance of...
10.
Stein D, Warner B, Audet J, Soule G, Siragam V, Sroga P, et al.
PLoS Pathog
. 2021 Oct;
17(10):e1009966.
PMID: 34634087
Nigeria continues to experience ever increasing annual outbreaks of Lassa fever (LF). The World Health Organization has recently declared Lassa virus (LASV) as a priority pathogen for accelerated research leading...